Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC401052 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KDM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NIPAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLCD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NXPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CELF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf173-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYHR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD54 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102723526 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5G1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCBD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPME1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on